Microbiology FDA 483 (Zydus Lifesciences): Procedures to prevent microbiological contamination are not followed
Procedure 0317-SOP-MFG-00039 “Clean room and aseptic behavior” was not followed to ensure sterilized components are only contacted with sterile forceps